High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men
Abstract
Objective—: Overproduction of hepatic apolipoprotein B (apoB)-100 containing very low-density lipoprotein particles and intestinal apoB-48 containing chylomicrons contributes to hypertriglyceridemia seen in conditions such as obesity and insulin resistance. Some, but not all, preclinical and clinical studies have demonstrated that the polyphenol resveratrol ameliorates insulin resistance and hypertriglyceridemia. Here, we assessed intestinal and hepatic lipoprotein turnover, in humans, after 2 weeks of treatment with resveratrol (1000 mg daily for week 1 followed by 2000 mg daily for week 2) or placebo. Approach and Results—: Eight overweight or obese individuals with mild hypertriglyceridemia were studied on 2 occasions, 4 to 6 weeks apart, after treatment with resveratrol or placebo in a randomized, double-blinded, crossover study. Steady-state lipoprotein kinetics was assessed in a constant fed state with a primed, constant infusion of deuterated leucine. Resveratrol treatment did not significantly affect insulin sensitivity (homeostasis model of assessment of insulin resistance), fasting or fed plasma triglyceride concentration. Resveratrol reduced apoB-48 production rate by 22% ( P =0.007) with no significant effect on fractional catabolic rate. Resveratrol reduced apoB-100 production rate by 27% ( P =0.02) and fractional catabolic rate by 26% ( P =0.04). Conclusions—: These results indicate that 2 weeks of high-dose resveratrol reduces intestinal and hepatic lipoprotein particle production. Long-term studies are needed to evaluate the potential clinical benefits of resveratrol in patients with hypertriglyceridemia, who have increased concentrations of triglyceride-rich lipoprotein apoB-100 and apoB-48. Clinical Trial Registration—: URL: www.clinicaltrials.gov . Unique identifier: NCT01451918.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Dash et al.'s crossover study, resveratrol (1000 mg/day first week, 2000 mg/day second week) for 2 weeks in overweight/obese subjects with mild hypertriglyceridemia produced no changes in insulin sensitivity or triglyceride concentration.
“The authors found no changes in insulin sensitivity and triglyceride concentration, but they observed a significant reduction in apoB-48 and apoB-100, which are lipoprotein particles produced by the intestine and liver, respectively [39].”
From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [39]
In Dash et al.'s study, resveratrol significantly reduced apoB-48 and apoB-100.
“The authors found no changes in insulin sensitivity and triglyceride concentration, but they observed a significant reduction in apoB-48 and apoB-100, which are lipoprotein particles produced by the intestine and liver, respectively [39].”
From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · see citing works
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · see citing works
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,788 · see citing works
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624 · see citing works
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358 · see citing works
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,352 · see citing works
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · see citing works
Heilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., Nguyen, T., Martin, C. K., Volaufova, J., Most, M. M., et al. (2006) · JAMA · doi:10.1001/jama.295.13.1539 · Cited by 969 · see citing works
Long-Term Calorie Restriction Is Highly Effective in Reducing the Risk for Atherosclerosis in Humans
Fontana, L., Meyer, T. E., Klein, S., & Holloszy, J. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308291101 · Cited by 902 · see citing works
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 691 · see citing works
Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000316 · Cited by 680 · see citing works
Zang, M., Xu, S., Maitland, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2006) · Diabetes · doi:10.2337/db05-1188 · Cited by 663 · see citing works
High-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455 · see citing works
Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S., Schechtman, K. B., Gu, C. C., Kunz, I., Fanelli, F. R., Patterson, B. W., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.015 · Cited by 381 · see citing works
Sirtuins mediate mammalian metabolic responses to nutrient availability
Chalkiadaki, A., & Guarente, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.225 · Cited by 342 · see citing works
Pilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281 · see citing works
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274 · see citing works
Tomé‐Carneiro, J., Gonzálvez, M., Larrosa, M., García‐Almagro, F. J., Avilés-Plaza, F. V., Parra, S., Yáñez-Gascón, M. J., Ruiz‐Ros, J. A., García‐Conesa, M., Tomás-Barberán, F. A., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100673 · Cited by 211 · see citing works
Duez, H., Lamarche, B., Uffelman, K. D., Valéro, R., Cohn, J. S., & Lewis, G. F. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222015.76038.14 · Cited by 188 · see citing works
Self-citationXiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.246207 · Cited by 164 · see citing works
Self-citationWang, G., Fu, Y., Xu, W., Feng, Y.-Q., Fang, S.-R., & Zhou, X. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.163 · Cited by 143 · see citing works
Chen, W.-L., Kang, C.-H., Wang, S.-G., & Lee, H.-M. (2012) · Diabetologia · doi:10.1007/s00125-012-2530-4 · Cited by 134 · see citing works
Intestinal lipoprotein overproduction in insulin-resistant states
Adeli, K., & Lewis, G. F. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ffaf82 · Cited by 130 · see citing works
Self-citationCho, S.-J., Jung, U. J., & Choi, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000347 · Cited by 130 · see citing works
Hogue, J., Lamarche, B., Tremblay, A. J., Bergeron, J., Gagné, C., & Couture, P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600548-jlr200 · Cited by 127 · see citing works
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 126 · see citing works
Self-citationDuez, H., Lamarche, B., Valéro, R., Pavlic, M., Proctor, S. D., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Circulation · doi:10.1161/circulationaha.107.739888 · Cited by 114 · see citing works
Self-citationPavlic, M., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2009) · Diabetes · doi:10.2337/db09-1297 · Cited by 102 · see citing works
Self-citationXiao, C., Pavlic, M., Szeto, L., Patterson, B. W., & Lewis, G. F. (2010) · Diabetes · doi:10.2337/db10-0763 · Cited by 60 · see citing works
Self-citationHernàndez-Vallejo, S. J., Alqub, M., Luquet, S. H., Cruciani‐Guglielmacci, C., Delerive, P., Lobaccaro, J. A., Kalopissis, A. D., Chambaz, J., Rousset, M., & Lacorte, J. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90324.2008 · Cited by 58 · see citing works
Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300769 · Cited by 56 · see citing works
Self-citationFroguel, P., Marquez, M., & Cauchi, S. (2012) · Diabetes · doi:10.2337/db12-0800 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Veilleux A, Grenier E, Carpentier A, Richard D, Levy E. Alterations in intestinal insulin signaling in obese subjects and their effect on lipid and lipoprotein metabolism (abstract). Diabetes. 2012;61:A15.
Cited by
Sorted by citations
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678 · see citing works
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 576 · see citing works
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523 · see citing works
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452 · see citing works
Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review
Amiot, M. J., Riva, C., & Vinet, A. (2016) · Obesity Reviews · doi:10.1111/obr.12409 · Cited by 448 · see citing works
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works
Resveratrol and diabetes: from animal to human studies.
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2014.10.013 · Cited by 322 · see citing works
Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.016 · Cited by 340 · see citing works
Liu, K., Zhou, R., Wang, B., & Mi, M. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082024 · Cited by 324 · see citing works
The pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302 · see citing works
Potì, F., Santi, D., Spaggiari, G., Zimetti, F., & Zanotti, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020351 · Cited by 256 · see citing works
Health Effects of Resveratrol: Results from Human Intervention Trials
Ramírez-Garza, S. L., Santos, E. P. L., Marhuenda‐Muñoz, M., Storniolo, C. E., Tresserra‐Rimbau, A., Vallverdú‐Queralt, A., & Lamuela-Raventós, R. M. (2018) · Nutrients · doi:10.3390/nu10121892 · Cited by 251 · see citing works
Resveratrol, Metabolic Syndrome, and Gut Microbiota
Chaplin, A. M. L., Carpéné, C., & Mercader, J. (2018) · Nutrients · doi:10.3390/nu10111651 · Cited by 248 · see citing works
Resveratrol supplementation: Where are we now and where should we go?
Novelle, M. G., Wahl, D., Diéguez, C., Bernier, M., & de Cabo, R. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.002 · Cited by 247 · see citing works
The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
Li, S., Tan, H., Wang, N., Cheung, F., Hong, M., & Feng, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8394818 · Cited by 199 · see citing works
New insights into the regulation of chylomicron production
Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034338 · Cited by 194 · see citing works
Self-citationNovel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160 · see citing works
Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism
Zanotti, I., Dall’Asta, M., Mena, P. R., Mele, L., Bruni, R., Ray, S., & Rio, D. D. (2014) · Food & Function · doi:10.1039/c4fo00670d · Cited by 158 · see citing works
Bo, S., Ponzo, V., Ciccone, G., Evangelista, A., Saba, F., Goitre, I., Procopio, M., Pagano, G. F., Cassader, M., & Gambino, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.010 · Cited by 146 · see citing works
Malhotra, A., Bath, S., & Elbarbry, F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/803971 · Cited by 143 · see citing works
Timmers, S., de Ligt, M., Esther Phielix, E., van de Weijer, T., Hansen, J., Moonen‐Kornips, E., Schaart, G., Kunz, I., Hesselink, M. K. C., Schrauwen‐Hinderling, V. B., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0499 · Cited by 138 · see citing works
Resveratrol and obesity: can resveratrol relieve metabolic disturbances?
de Ligt, M., Timmers, S., & Schrauwen, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.012 · Cited by 135 · see citing works
The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
Izzo, C., Annunziata, M., Melara, G., Sciorio, R., Dallio, M., Masarone, M., Federico, A., & Persico, M. (2021) · Nutrients · doi:10.3390/nu13030933 · Cited by 134 · see citing works
van der Made, S. M., Plat, J., & Mensink, R. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118393 · Cited by 131 · see citing works
Resveratrol, human health and winemaking perspectives
Pastor, R. F., Restani, P., Di Lorenzo, C., Orgiu, F., Teissedre, P.-L., Stockley, C., Ruf, J. C., Quini, C. I., Garcìa Tejedor, N., Gargantini, R., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1400517 · Cited by 123 · see citing works
Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art
Pagliaro, B., Santolamazza, C., Simonelli, F., & Rubattu, S. D. (2015) · BioMed Research International · doi:10.1155/2015/918069 · Cited by 115 · see citing works
Significance of Resveratrol in Clinical Management of Chronic Diseases
Wahab, A., Gao, K., Jia, C., Zhang, F., Tian, G., Murtaza, G., & Chen, J. (2017) · Molecules · doi:10.3390/molecules22081329 · Cited by 107 · see citing works
Human Sirtuin Regulators: The “Success” Stories
Curry, A. M., White, D. S., Donu, D., & Cen, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.752117 · Cited by 105 · see citing works
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility
Oyenihi, O. R., Oyenihi, A. B., Adeyanju, A. A., & Oguntibeju, O. O. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9737483 · Cited by 103 · see citing works
Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies
Feldman, F., Koudoufio, M., Desjardins, Y., Spahis, S., DELVIN, E. E., & Levy, E. H. (2021) · Nutrients · doi:10.3390/nu13020672 · Cited by 82 · see citing works
Adipose tissue NAD + biology in obesity and insulin resistance: From mechanism to therapy
Yamaguchi, S., & Yoshino, J. (2017) · BioEssays · doi:10.1002/bies.201600227 · Cited by 83 · see citing works
de Ligt, M., Bruls, Y. M. H., Hansen, J., Habets, M.-F., Havekes, B., Nascimento, E. B. M., Moonen-Kornips, E., Schaart, G., Schrauwen-Hinderling, V. B., van Marken Lichtenbelt, W., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.004 · Cited by 79 · see citing works
Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance
Revelo, X. S., Ghazarian, M., Chng, M. H. Y., Luck, H., Kim, J. H., Zeng, K., Shi, S. Y., Tsai, S. J., Lei, H., Kenkel, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.024 · Cited by 78 · see citing works
Self-citationGuthrie, A. R., Chow, H. ‐. S., & Martinez, J. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.294 · Cited by 78 · see citing works
Recent advances in triacylglycerol mobilization by the gut
Xiao, C., Stahel, P., Carreiro, A. L., Buhman, K. K., & Lewis, G. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.12.001 · Cited by 77 · see citing works
Self-citationLiu, C., Liao, J., & Li, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i11.1964 · Cited by 75 · see citing works
Dual PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction
Kalliora, C., Kyriazis, I. D., Oka, S., Lieu, M., Yue, Y., Área-Gómez, E., Pol, C. J., Tian, Y., Mizushima, W., Chin, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129556 · Cited by 75 · see citing works
The Role of Resveratrol Administration in Human Obesity
Mongioì, L. M., La Vignera, S., Cannarella, R., Cimino, L., Compagnone, M., Condorelli, R. A., & Calogero, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094362 · Cited by 71 · see citing works
Are epigenetic drugs for diabetes and obesity at our door step?
Arguelles, A. O., Meruvu, S., Bowman, J. D., & Choudhury, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.001 · Cited by 70 · see citing works
Korsholm, A. S., Kjær, T. N., Ørnstrup, M. J., & Pedersen, S. B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030554 · Cited by 71 · see citing works
Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor
Xue, Z., Li, D., Yu, W., Zhang, Q., Hou, X., He, Y., & Kou, X. (2017) · Food & Function · doi:10.1039/c6fo01810f · Cited by 73 · see citing works
Huang, H., Chen, G., Liao, D., Zhu, Y., Pu, R., & Xue, X. (2016) · Obesity Reviews · doi:10.1111/obr.12458 · Cited by 66 · see citing works
Novel therapeutics for type 2 diabetes: insulin resistance
Altaf, Q. A., Barnett, A. H., & Tahrani, A. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12400 · Cited by 64 · see citing works
Oshaghi, E. A., Goodarzi, M. T., Higgins, V., & Adeli, K. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1343274 · Cited by 62 · see citing works
Navarro, G., Martínez‐Pinilla, E., Ortiz, R., Noé, V., Ciudad, C. J., & Franco, R. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12359 · Cited by 63 · see citing works
de Ligt, M., Bergman, M., Mancilla, R., Essers, J. M. N. H., Moonen‐Kornips, E., Havekes, B., Schrauwen‐Hinderling, V. B., & Schrauwen, P. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa125 · Cited by 60 · see citing works
New and emerging regulators of intestinal lipoprotein secretion
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.047 · Cited by 59 · see citing works
Self-citationPang, J., Raka, F., Heirali, A., Shao, W., Liu, D., Gu, J., Feng, J. N., Mineo, C., Shaul, P. W., Qian, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38259-1 · Cited by 57 · see citing works
Remnant cholesterol and ischemic heart disease
Varbo, A., & Nordestgaard, B. G. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000093 · Cited by 56 · see citing works
Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12877 · Cited by 54 · see citing works
Challenges in Analyzing the Biological Effects of Resveratrol
Erdogan, C. S., & Vang, O. (2016) · Nutrients · doi:10.3390/nu8060353 · Cited by 54 · see citing works
The Potential to Fight Obesity with Adipogenesis Modulating Compounds
Zhao, J., Zhou, A., & Qi, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042299 · Cited by 54 · see citing works
Xu, J., Shen, J., Yuan, R., Jia, B., Zhang, Y., Wang, S., Zhang, Y., Liu, M., & Wang, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.796207 · Cited by 53 · see citing works
Resveratrol Action on Lipid Metabolism in Cancer
Kisková, T., & Kassayová, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112704 · Cited by 53 · see citing works
Resveratrol preserves the function of human platelets stored for transfusion
Lannan, K. L., Refaai, M. A., Ture, S. K., Morrell, C. N., Blumberg, N., Phipps, R. P., & Spinelli, S. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13862 · Cited by 50 · see citing works
Jing, Y., Hu, T., Lin, C., Xiong, Q., Liu, F., Yuan, J. J., Zhao, X., & Wang, R. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.019 · Cited by 50 · see citing works
Christenson, J., Whitby, S. J., Mellor, D., Thomas, J., McKune, A., Roach, P. D., & Naumovski, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0035 · Cited by 47 · see citing works
García‐Conesa, M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.980499 · Cited by 47 · see citing works
Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging
Uddin, M. J., Farjana, M., Moni, A., Hossain, K. S., Hannan, M. A., & Ha, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158258 · Cited by 47 · see citing works
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Pereira, T. D. M. C., Pimenta, F. S., Porto, M. L., Baldo, M. P., Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081273 · Cited by 43 · see citing works
Poulsen, M. K., Nellemann, B., Bibby, B. M., Stødkilde‐Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13409 · Cited by 41 · see citing works
Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
García-Martínez, B. I., Ruíz-Ramos, M., Pedraza‐Chaverrí, J., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Antioxidants · doi:10.3390/antiox10010069 · Cited by 39 · see citing works
Liudvytska, O., & Kołodziejczyk-Czepas, J. (2022) · Nutrients · doi:10.3390/nu14102053 · Cited by 38 · see citing works
González-Gómez, Á., Cantone, M., García‐Muñoz, A. M., Victoria‐Montesinos, D., Lucas-Abellán, C., Serrano‐Martínez, A., Muñoz-Morillas, A. M., & Morillas-Ruiz, J. M. (2025) · Nutrients · doi:10.3390/nu17152468 · Cited by 37 · see citing works
Critical review of resveratrol in xenobiotic-induced hepatotoxicity
McGill, M. R., Du, K., Weemhoff, J. L., & Jaeschke, H. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.11.003 · Cited by 37 · see citing works
Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms
Renaud, J., & Martinoli, M. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617101332 · Cited by 36 · see citing works
The role of resveratrol in diabetes and obesity associated with insulin resistance
Hoca, M., Becer, E., & Vatansever, H. S. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1893338 · Cited by 36 · see citing works
Dolinsky, V. W., & Dyck, J. R. B. (2014) · Molecules · doi:10.3390/molecules190914919 · Cited by 34 · see citing works
O’Tierney-Ginn, P., Roberts, V. H. J., Gillingham, M. B., Walker, J., Glazebrook, P. A., Thornburg, K. L. R., Grove, K. L., & Frias, A. E. (2015) · Placenta · doi:10.1016/j.placenta.2015.06.002 · Cited by 33 · see citing works
Saad, N. M., Sekar, M., Gan, S. H., Lum, P. T., Vaijanathappa, J., & Ravi, S. (2020) · Pharmacognosy Journal · doi:10.5530/pj.2020.12.240 · Cited by 30 · see citing works
Aloui, F., Charradi, K., Hichami, A., Selvakumar, S., Khan, N. A., Limam, F., & Aouani, E. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.017 · Cited by 30 · see citing works
Ou, S. J. L., Yang, D., Pranata, H. P., Tai, E. S., & Liu, M. H. (2023) · npj Science of Food · doi:10.1038/s41538-023-00233-y · Cited by 28 · see citing works
Sergi, C. M., Chiu, B., Feulefack, J., Shen, F., & Chiu, B. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.95884 · Cited by 23 · see citing works
Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427092114 · Cited by 21 · see citing works
Wang, X., Zhang, C., Huang, G., Han, D., Guo, Y. C., Meng, X., & Kan, C. (2015) · PubMed Central · Cited by 19 · see citing works
The Clock‐NAD+‐Sirtuin connection in nonalcoholic fatty liver disease
Aggarwal, S., Trehanpati, N., Nagarajan, P., & Ramakrishna, G. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30772 · Cited by 17 · see citing works
The Growing Problem of Obesity
Schmidt, A. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305753 · Cited by 17 · see citing works
Bedhiafi, T., Charradi, K., Azaiz, M. B., Mahmoudi, M., Msakni, I., Jebari, K., Bouziani, A., Limam, F., & Aouani, E. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0743 · Cited by 17 · see citing works
Tehrani, S. D., Shojaei, M., Bagherniya, M., Pirro, M., & Sahebkar, A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7763 · Cited by 13 · see citing works
The Journey of Resveratrol from Vineyards to Clinics
Venkat, R., Verma, E., Daimary, U. D., Kumar, A., Girisa, S., Dutta, U., Ahn, K. S., & Kunnumakkara, A. B. (2022) · Cancer Investigation · doi:10.1080/07357907.2022.2115057 · Cited by 12 · see citing works
Aterofisiol® in carotid plaque evolution
Serra, R., Amato, B., Compagna, R., Amato, M., Gallelli, L., & de Franciscis, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87609 · Cited by 10 · see citing works
Effects of resveratrol on mitochondrial biogenesis and physiological diseases
Uriho, A., Xue Ming, T. A. N. G., Le, G., Yang, S., Harimana, Y., Papy, I. S., Yiping, L., Zhang, K., Ma, S., & Muhoza, B. (2020) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00492-0 · Cited by 9 · see citing works
The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport
Jiang, Y., Pang, S., Liu, X., Wang, L., & Liu, Y. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10480-3 · Cited by 8 · see citing works
Xenohormesis: Applying Evolutionary Principles to Contemporary Health Issues
Suter, S., & Lucock, M. D. (2017) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2017.00023 · Cited by 7 · see citing works
Grape Polyphenols in the Prevention of Cardiovascular Disease
Gross, M. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28995-3_3 · Cited by 6 · see citing works
Resveratrol: Is It Really Good for Liver Health?
Weiskirchen, S., & Weiskirchen, R. (2017) · Hepatitis Monthly · doi:10.5812/hepatmon.12074 · Cited by 5 · see citing works
Robberecht, H. J., Bruyne, T. D., & Hermans, N. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9538-9 · Cited by 6 · see citing works
Cai, Y., & Chen, Q. (2024) · Phytotherapy Research · doi:10.1002/ptr.8416 · Cited by 4 · see citing works
Dietary intake of plant polyphenols: Exploring trend in the Czech population
Sedláček, P., Bludovská, M., Plavinová, I., Zavaďáková, A., Müller, L., & Müllerová, D. (2024) · Central European Journal of Public Health · doi:10.21101/cejph.a7994 · Cited by 3 · see citing works
Casademont‐Roca, A., Tomassen, M. M. M., Kersten, S., Steegenga, W. T., Hooiveld, G. J. E. J., & Mes, J. J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70311 · Cited by 2 · see citing works
Phytochemicals alter foam cell formation and macrophage cholesterol efflux
Pan, Z., & Ling, W. (2026) · Metabolism and Diseases · doi:10.1016/j.metdis.2026.100003 · Cited by 1 · see citing works
Efeitos do resveratrol nas células cancerígenas
de Souza, G. D. N. B., & Ferreira, J. C. D. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i6.28841 · Cited by 1 · see citing works
Review of resveratrol for the management of hyperlipidemia and survey
Shelton, A. N., Potts, L. T., & Hailemeskel, B. (2023) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2023.9.1.0338 · Cited by 1 · see citing works
Obesity and Cardiovascular Disease: Impact of Resveratrol as a Therapeutic
Louis, X. L., Krishnan, S. K., Wigle, J. T., & Netticadan, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_15 · Cited by 1 · see citing works
20. Resveratrol and metabolic syndrome in obese men – a review
Solverson, P. M., Novotny, J. A., & Castonguay, T. W. (2017) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-853-7_20
Bruls, Y. M. H. (2018) · doi:10.26481/dis.20180614yb
Pharmacological Treatment for Aging: Are We There?
Barrera-Vázquez, O. S., & Gómez-Verján, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_12
Kumhyr, I. R. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i3.10708
Björnson, E. (2021) · Gothenburg University Publications Electronic Archive (Gothenburg University)
- Authors
- Dash, S., Xiao, C., Morgantini, C., Szeto, L., & Lewis, G. F.
- Affiliations
- Scuola Superiore Sant'Anna (IT)
- Corresponding author
- Dash, Satya
- Xiao, Changting
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2013-12
- Volume
- 33
- Issue
- 12
- Pages
- 2895-2901
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2165712074
- Cited by
- 102
- References
- 33
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 12 · 2016: 13 · 2015: 15 · 2014: 10
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- resveratrol, hypertriglyceridemia, apolipoprotein B-100, apolipoprotein B-48, VLDL, chylomicrons, lipoprotein production, lipoprotein turnover, fractional catabolic rate, obesity, insulin resistance, triglyceride-rich lipoproteins
- MeSH terms
- Resveratrol, Adult, Analysis of Variance, Hypolipidemic Agents, Double-Blind Method, Drug Administration Schedule, Humans, Insulin Resistance, Intestinal Mucosa, Intestines, Lipoproteins, Liver, Male, Middle Aged, Obesity, Ontario, Stilbenes, Time Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Treatment Outcome, Cross-Over Studies, Overweight, Apolipoprotein B-48, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
